Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients. Insurers selling coverage in North Carolina, Pennsylvania and New York, ...

A bill making its way through the Nebraska Legislature would require state-regulated health plans to cover US Food and Drug Administration-approved dementia treatments and diagnostics as well as ...

Rural Americans face higher Alzheimer's risk but often lack access to specialists and early diagnostic tools, prompting calls ...

Roughly 62,500 people in the state of Mississippi are living with Alzheimer’s disease.

JACKSON, Miss. (WLBT) - Mississippi is a hot spot in the nation for Alzheimer’s disease. Now lawmakers are being urged to support early diagnosis methods. Medical professionals, advocates, and those ...

Publisher's note: This series was paid for by National Minority Quality Forum. The views expressed are the authors' own. Nearly seven million Americans currently live with Alzheimer's disease, a ...

SB 950 offers a clear answer. It affirms that in California, when science advances, patients should not be left behind.

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier ...

Canada's Drug Agency says a medication to slow early-stage Alzheimer’s disease should not be covered by public drug plans.